These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38884423)

  • 1. Subclinical effects of botulinum toxin A and microwave thermolysis for axillary hyperhidrosis: A descriptive study with line-field confocal optical coherence tomography and histology.
    Grove GL; Jacobsen K; Maartensson NL; Haedersdal M
    Exp Dermatol; 2024 Jun; 33(6):e15110. PubMed ID: 38884423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study.
    Wu CJ; Chang CK; Wang CY; Liao YS; Chen SG
    Dermatol Surg; 2019 Dec; 45(12):1605-1609. PubMed ID: 30829777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A versus microwave thermolysis for primary axillary hyperhidrosis: A randomized controlled trial.
    Grove GL; Togsverd-Bo K; Zachariae C; Haedersdal M
    JAAD Int; 2024 Jun; 15():91-99. PubMed ID: 38495540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histological evaluation of a single high energy microwave treatment for primary axillary hyperhidrosis in Asians: A prospective, randomized, controlled, split-area comparative trial.
    Kaminaka C; Mikita N; Inaba Y; Kunimoto K; Okuhira H; Jinnin M; Kao B; Tanino R; Tanioka K; Shimokawa T; Yamamoto Y
    Lasers Surg Med; 2019 Sep; 51(7):592-599. PubMed ID: 30811620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
    Kreyden OP; Scheidegger EP
    Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosis.
    Grove GL; Togsverd-Bo K; Schwensen JFB; Andersson NW; Nissen CV; Zachariae C; Haedersdal M
    Lasers Surg Med; 2023 Jan; 55(1):105-115. PubMed ID: 36229952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.
    Rompel R; Scholz S
    J Eur Acad Dermatol Venereol; 2001 May; 15(3):207-11. PubMed ID: 11683282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution.
    Hölzle E; Braun-Falco O
    Br J Dermatol; 1984 Apr; 110(4):399-403. PubMed ID: 6712884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
    Glogau RG
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study.
    Lueangarun S; Sermsilp C; Tempark T
    Dermatol Surg; 2018 Aug; 44(8):1094-1101. PubMed ID: 29659406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.
    Glaser DA
    J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
    Odderson IR
    Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin.
    Swartling C; Naver H; Pihl-Lundin I; Hagforsen E; Vahlquist A
    J Am Acad Dermatol; 2004 Nov; 51(5):739-45. PubMed ID: 15523352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis.
    Yang H; Kang J; Zhang S; Peng K; Deng B; Cheng B
    Thorac Cardiovasc Surg; 2019 Aug; 67(5):402-406. PubMed ID: 30216949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A.
    Heckmann M; Teichmann B; Pause BM; Plewig G
    Arch Dermatol; 2003 Jan; 139(1):57-9. PubMed ID: 12533165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: a randomized, controlled trial.
    Montaser-Kouhsari L; Zartab H; Fanian F; Noorian N; Sadr B; Nassiri-Kashani M; Firooz A
    J Dermatolog Treat; 2014 Aug; 25(4):337-41. PubMed ID: 23106157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.